APA

Eschbach R. S., Fendler W. P., Kazmierczak P. M., Hacker M., Rominger A., Carlsen J., Hirner-Eppeneder H., Schuster J., Moser M., Havla L., Schneider M. J., Ingrisch M., Spaeth L., Reiser M. F., Nikolaou K. & Cyran C. C. (20160114). Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation. : PloS one.

Chicago

Eschbach Ralf S, Fendler Wolfgang P, Kazmierczak Philipp M, Hacker Marcus, Rominger Axel, Carlsen Janette, Hirner-Eppeneder Heidrun, Schuster Jessica, Moser Matthias, Havla Lukas, Schneider Moritz J, Ingrisch Michael, Spaeth Lukas, Reiser Maximilian F, Nikolaou Konstantin and Cyran Clemens C. 20160114. Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation. : PloS one.

Harvard

Eschbach R. S., Fendler W. P., Kazmierczak P. M., Hacker M., Rominger A., Carlsen J., Hirner-Eppeneder H., Schuster J., Moser M., Havla L., Schneider M. J., Ingrisch M., Spaeth L., Reiser M. F., Nikolaou K. and Cyran C. C. (20160114). Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation. : PloS one.

MLA

Eschbach Ralf S, Fendler Wolfgang P, Kazmierczak Philipp M, Hacker Marcus, Rominger Axel, Carlsen Janette, Hirner-Eppeneder Heidrun, Schuster Jessica, Moser Matthias, Havla Lukas, Schneider Moritz J, Ingrisch Michael, Spaeth Lukas, Reiser Maximilian F, Nikolaou Konstantin and Cyran Clemens C. Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation. : PloS one. 20160114.